Xiangyu Medical Co.,Ltd (SHA:688626)
China · Delayed Price · Currency is CNY 58.10
0.00 (0.00%)
Apr 24, 2026, 3:00 PM CST
Xiangyu Medical Co.,Ltd Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 78.36 | 75.99 | 102.94 | 227.14 | 125.47 | 201.9 |
Depreciation & Amortization | 55.67 | 55.67 | 37.95 | 18.08 | 16.06 | 11.37 |
Other Amortization | 8.17 | 8.17 | 3.99 | 1.51 | 1.63 | 0.48 |
Loss (Gain) From Sale of Assets | -0.03 | -0.03 | -0.07 | -0.01 | - | -0.02 |
Asset Writedown & Restructuring Costs | 7.74 | 7.74 | 0.05 | 0.02 | 0.25 | 0.04 |
Loss (Gain) From Sale of Investments | -5.94 | -5.94 | -1.4 | -6.06 | -12.59 | -12.13 |
Provision & Write-off of Bad Debts | - | - | 3.19 | 2.15 | 0.07 | 2.2 |
Other Operating Activities | 9.97 | 9.32 | 13.66 | 13.49 | 3.03 | 0.49 |
Change in Accounts Receivable | 5.13 | 5.13 | -20.71 | -44.14 | 18.03 | -31.44 |
Change in Inventory | -74.27 | -74.27 | -6 | -27.68 | -65.8 | -29.31 |
Change in Accounts Payable | 95.81 | 95.81 | 38.23 | 48.4 | 94.37 | 23.84 |
Change in Other Net Operating Assets | 16.58 | 16.58 | 5.1 | 2.83 | - | - |
Operating Cash Flow | 192.84 | 189.82 | 178.59 | 227.91 | 186.7 | 165.88 |
Operating Cash Flow Growth | 5.87% | 6.28% | -21.64% | 22.07% | 12.55% | -23.35% |
Capital Expenditures | -238.98 | -287.18 | -438.89 | -479.26 | -203.07 | -133.91 |
Sale of Property, Plant & Equipment | 0.08 | 0.08 | 0.08 | 0.09 | 0.07 | 0.04 |
Divestitures | 5.15 | 5.15 | - | 0.23 | - | - |
Investment in Securities | -15.75 | -5.75 | 161.8 | 232.42 | 5.42 | -657.2 |
Other Investing Activities | -28.71 | -108.59 | 1.26 | 11.98 | 18.68 | 9.03 |
Investing Cash Flow | -278.21 | -396.29 | -275.76 | -234.54 | -178.9 | -782.04 |
Short-Term Debt Issued | - | - | 516 | 82 | 60.15 | - |
Long-Term Debt Issued | - | 300.63 | - | - | - | - |
Total Debt Issued | 284.39 | 300.63 | 516 | 82 | 60.15 | - |
Short-Term Debt Repaid | - | - | -202.68 | -73.3 | -47.78 | -50.09 |
Long-Term Debt Repaid | - | -529.71 | -1.51 | -1.09 | - | - |
Total Debt Repaid | -432.72 | -529.71 | -204.18 | -74.38 | -47.78 | -50.09 |
Net Debt Issued (Repaid) | -148.33 | -229.08 | 311.82 | 7.62 | 12.37 | -50.09 |
Issuance of Common Stock | - | - | - | - | - | 1,086 |
Repurchase of Common Stock | - | - | -77.57 | -25.66 | -73.27 | - |
Common Dividends Paid | -39.36 | -44.43 | -85.59 | -40.46 | -59.94 | -59.41 |
Other Financing Activities | 281.03 | 460.58 | -0.28 | - | 3.8 | -21.08 |
Financing Cash Flow | 93.34 | 187.06 | 148.38 | -58.5 | -117.04 | 955.13 |
Foreign Exchange Rate Adjustments | -0.09 | -0.25 | -0.07 | -0.02 | -0.02 | -0.02 |
Net Cash Flow | 7.88 | -19.66 | 51.15 | -65.15 | -109.27 | 338.95 |
Free Cash Flow | -46.14 | -97.37 | -260.3 | -251.35 | -16.37 | 31.97 |
Free Cash Flow Growth | - | - | - | - | - | -58.31% |
Free Cash Flow Margin | -5.96% | -12.68% | -35.01% | -33.75% | -3.35% | 6.11% |
Free Cash Flow Per Share | -0.30 | -0.64 | -1.67 | -1.59 | -0.10 | 0.21 |
Cash Interest Paid | - | - | - | - | 0.19 | - |
Cash Income Tax Paid | 48.7 | 47.15 | 44.21 | 58.42 | 43.73 | 62.21 |
Levered Free Cash Flow | -375.67 | -410.78 | -346.73 | -391.43 | -65.55 | -56.43 |
Unlevered Free Cash Flow | -375.67 | -410.78 | -344.46 | -389.77 | -65.43 | -56.43 |
Change in Working Capital | 38.89 | 38.89 | 18.28 | -28.42 | 52.78 | -38.45 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.